Discovering innovative cancer therapies
From initial concept to the delivery of candidate drugs - we're a drug discovery company specialising in cutting-edge treatments for diseases with an unmet need
Learn about usMore than 10 years of experience in advancing novel concepts to candidate drug selection
Our track record of excellence means that we partner with some of the world's most innovative and established biotechnology and pharmaceutical companies.
An extensive pipeline of R&D programmes
From concept to the delivery of candidate drugs, Sentinel Oncology is developing a portfolio of new therapies and is committed to improving the treatment options for patients
View our pipelineOur upcoming events
Our latest news
-
Sentinel Oncology receive Innovate UK grant to study feasibility of drug in the treatment of Alzheimer's disease
Read article -
Sentinel Oncology and NMI TT Pharmaservices awarded Eurostars grant for development of a novel biomarker for the treatment of Fragile X Syndrome
Read article
Meet the team & board"It's our vision to develop oncology drugs that are devoid of the systemic toxicities often associated with chemotherapeutics"